News - Valeant Pharmaceuticals, Markets & Marketing

Filter

Popular Filters

Actavis settles with Valeant to launch generic Ziana and Zyclara in USA

11-04-2013

US generics drug major Actavis (NYSE: ACT) has reached settlement agreements with Medicis Pharmaceutical,…

ActavisGenericsMarkets & MarketingNorth AmericaPatentsValeant PharmaceuticalsZiana GelZyclara

Actavis and Valeant to co-promote Zovirax and Cordran Tape

07-04-2013

Valeant Pharmaceuticals International (TSX: VRX) entered into an agreement, effective immediately, for…

ActavisAnti-viralsCordran TapeGenericsLicensingMarkets & MarketingMylan LaboratoriesNorth AmericaValeant PharmaceuticalsZovirax Ointment

Eisai enters deals with Valeant and Minophagen

04-04-2012

The European subsidiary of Japanese drug major Eisai (TYO: 4523) and PharmaSwiss, a division of Canada-based…

bexaroteneEisaiHalavenLicensingMarkets & MarketingMinophagenOncologyPharmaceuticalValeant Pharmaceuticals

US FTC updates on Valeant dermatology acquisitions

23-02-2012

Following public comment periods for both transactions, the US Federal Trade Commission has approved…

DermatologicalsMarkets & MarketingPharmaceuticalValeant Pharmaceuticals

BioDelivery pain drug Onsolis to launch in Canada via Meda Valeant

22-08-2011

US specialty drug firm BioDelivery Sciences International (Nasdaq: BDSI) says that its pain drug Onsolis…

BioDelivery SciencesMarkets & MarketingMedaMeda ValeantNeurologicalNorth AmericaOnsolisPharmaceuticalValeant Pharmaceuticals

Back to top